Add to Cart View Cart/Checkout More Products

Volume 19, 2015 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2015 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 19 No. 1 January/February 2015 Volume 19, Number 1
Vol. 19 No. 2 March/April 2015 Volume 19, Number 2
Vol. 19 No. 3 May/June 2015 Volume 19, Number 3
Vol. 19 No. 4 July/August 2015 Volume 19, Number 4
Vol. 19 No. 5 September/October 2015 Volume 19, Number 5
Vol. 19 No. 6 November/December 2015 Volume 19, Number 6

Articles
Volume/IssuePageTitle
Vol. 19 No. 1 4 PreScription: 2014 in Review
Vol. 19 No. 1 6 Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Vol. 19 No. 1 14 Giving Back: A Win-Win Plan of Action for Compounding Pharmacists
Vol. 19 No. 1 18 Pharmacy Student Survey: Perceptions and Expectations of Pharmaceutical Compounding
Vol. 19 No. 1 30 Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance
Vol. 19 No. 1 38 Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1
Vol. 19 No. 1 43 Quality Control Analytical Methods: Refractive Index
Vol. 19 No. 1 49 Basics of Sterile Compounding: Aseptic Processing
Vol. 19 No. 1 57 Basics of Compounding: The Revised "Not to Compound List"
Vol. 19 No. 1 59 Calculations
Vol. 19 No. 1 60 Atenolol 25-, 50-, or 100-mg Capsules
Vol. 19 No. 1 61 Azathioprine 50-mg Capsules
Vol. 19 No. 1 62 Cisplatin 1-mg/mL Injection
Vol. 19 No. 1 63 Daunorubicin 5-mg/mL Injection
Vol. 19 No. 1 64 Erythromycin 50-mg/mL Injection
Vol. 19 No. 1 65 Hydralazine Hydrochloride 20-mg/mL Injection
Vol. 19 No. 1 66 Hydroxychloroquine Sulfate 200-mg Capsules
Vol. 19 No. 1 67 Lidocaine Hydrochloride 4% Topical Solution
Vol. 19 No. 1 68 Mupirocin 2% Ointment
Vol. 19 No. 1 69 Phentolamine Mesylate 5-mg/mL Injection
Vol. 19 No. 1 70 Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration
Vol. 19 No. 1 73 Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions
Vol. 19 No. 1 78 Stability of Suspensions: Theoretical and Practical Considerations before Compounding
Vol. 19 No. 1 86 PostScription: Pharmacists Advancing Toward Provider Status
Vol. 19 No. 2 92 PreScription: Some of the Best Sermons are Lived, not Preached!
Vol. 19 No. 2 94 New England Compounding Center Indictment
Vol. 19 No. 2 104 Standing Together Fixing the Drug Quality and Security Act
Vol. 19 No. 2 109 Standarized Compounding: The Importance of Doing it the Same Way Every Time
Vol. 19 No. 2 115 Bedside Manner: Not Just for Doctors Anymore
Vol. 19 No. 2 121 Quality Assurance and Quality Control, Part 1
Vol. 19 No. 2 127 Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing
Vol. 19 No. 2 140 Calculations
Vol. 19 No. 2 142 Acne Scrub
Vol. 19 No. 2 143 Aminohippurate Sodium 200-mg/mL Injection
Vol. 19 No. 2 144 Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Vol. 19 No. 2 145 Heparin 335-United/Gram Gel-Cream
Vol. 19 No. 2 146 L-Cysteine Hydrochloride 50-mg/mL Injection
Vol. 19 No. 2 147 Morrhuate Sodium 5% Injection
Vol. 19 No. 2 148 Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution
Vol. 19 No. 2 149 Pancuronium Bromide 1-mg/mL Injection
Vol. 19 No. 2 150 Physostigmine Salicylate 1-mg/mL Injection
Vol. 19 No. 2 151 Trypan Blue 0.06% Ophthalmic Solution
Vol. 19 No. 2 152 Transdermal Delivery of Nisoldipine: Refinement of Vehicles
Vol. 19 No. 2 161 Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Vol. 19 No. 2 167 Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Vol. 19 No. 2 174 PostScription: What's Your Patient Care Story?
Vol. 19 No. 3 180 PreScription: 2015 Student Pharmacist Compounding Competition
Vol. 19 No. 3 182 Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities
Vol. 19 No. 3 195 Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Vol. 19 No. 3 205 Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls
Vol. 19 No. 3 212 IACP Says: "Fix DQSA"
Vol. 19 No. 3 215 Quality Assurance and Quality Control, Part 2
Vol. 19 No. 3 223 Basics of Compounding: Compounding with Silicones
Vol. 19 No. 3 232 Basics of Sterile Compounding: Contamination Control
Vol. 19 No. 3 240 Calculations
Vol. 19 No. 3 242 Atropine Sulfate 1% Ophthalmic Solution
Vol. 19 No. 3 243 Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Vol. 19 No. 3 244 Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches
Vol. 19 No. 3 245 Phenazopyridine Hydrochloride 200-mg Capsules
Vol. 19 No. 3 246 Physostigmine Salicylate 1-mg/mL Injection
Vol. 19 No. 3 247 Scopolamine Hydrobromide -.4-mg/mL Injection
Vol. 19 No. 3 248 Stability of Metronidazole Suspensions
Vol. 19 No. 3 252 Protocol of Blood Serum Eye Drops
Vol. 19 No. 3 261 Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Vol. 19 No. 4 266 PreScription: Potpourri of Opinions…From Many
Vol. 19 No. 4 268 Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Vol. 19 No. 3 268 Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles
Vol. 19 No. 3 271 PostScription: Opportunities to Change the Pharmacy Landscape
Vol. 19 No. 4 280 Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2
Vol. 19 No. 4 289 Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Vol. 19 No. 4 295 Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Vol. 19 No. 4 303 U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Vol. 19 No. 4 307 Quality Control Analytical Methods: Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units
Vol. 19 No. 4 311 Basics of Compounding: The "Negative" List
Vol. 19 No. 4 315 Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing
Vol. 19 No. 4 322 Calculations
Vol. 19 No. 4 324 Ammonium Molybdate 25-mcg/mL Injection
Vol. 19 No. 4 325 Balsam Peru, Castor Oil, and Trypsin Ointment
Vol. 19 No. 4 326 Benzonatate 100-mg Capsules
Vol. 19 No. 4 327 Chloroquine Phosphate 250-mg Capsules
Vol. 19 No. 4 328 Cytarabine 50-mg/mL Injection
Vol. 19 No. 4 329 Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection
Vol. 19 No. 4 330 Oxytocin 10-units/mL Injection
Vol. 19 No. 4 331 Phytonadione 2-mg/mL Injection
Vol. 19 No. 4 332 Proparacaine Hydrochloride 0.5% Ophthalmic Solution
Vol. 19 No. 4 333 Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg
Vol. 19 No. 4 334 Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters
Vol. 19 No. 4 337 Stability of Prednisone in Oral Mix Suspending Vehicle
Vol. 19 No. 4 340 Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals
Vol. 19 No. 4 344 Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes
Vol. 19 No. 4 348 PostScription: APhA2015: You Spoke, We Listened, and What a Success!
Vol. 19 No. 5 354 PreScription: Failure or Success?
Vol. 19 No. 5 357 Novel Approaches to Topical Psoriasis Therapy
Vol. 19 No. 5 367 Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries
Vol. 19 No. 5 375 The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding
Vol. 19 No. 5 377 The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Vol. 19 No. 5 383 Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations
Vol. 19 No. 5 389 Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Vol. 19 No. 5 393 Sterile Filtration
Vol. 19 No. 5 402 Calculations
Vol. 19 No. 5 404 Aminocaproic Acid 250-mg/mL Oral Solution
Vol. 19 No. 5 405 Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Vol. 19 No. 5 406 Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment
Vol. 19 No. 5 407 Nimodipine 3-mg/mL Oral Solution
Vol. 19 No. 5 408 Ofloxacin 0.3% Otic Solution
Vol. 19 No. 5 409 Povidone Iodine 10% Cold Sore Paint
Vol. 19 No. 5 410 Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Vol. 19 No. 5 411 Vehicle for Oral Solution (National Formulary 26)
Vol. 19 No. 5 412 Vehicle for Oral Solution, Sugar Free (National Formulary 26)
Vol. 19 No. 5 413 Vehicle for Oral Suspension (National Formulary 26)
Vol. 19 No. 5 414 Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Vol. 19 No. 5 420 Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Vol. 19 No. 5 428 Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Vol. 19 No. 5 432 In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Vol. 19 No. 5 437 PostScription: Progress Report: Provider Status Continues to Gain Strength!
Vol. 19 No. 6 442 PreScription: The Documented Past and the Exciting Future
Vol. 19 No. 6 444 Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless Arithmetic Nullifies Careful Compounding"
Vol. 19 No. 6 449 International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance
Vol. 19 No. 6 453 Applying Quality of Design Concepts to Pharmacy Compounding
Vol. 19 No. 6 465 Root Cause Analysis, Part 1: Nonsterile Compounding
Vol. 19 No. 6 471 Basic Principles of Lyophilization, Part 1
Vol. 19 No. 6 479 Mixing in a Compounding Pharmacy in the 21st Century
Vol. 19 No. 6 487 U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Vol. 19 No. 6 491 Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Vol. 19 No. 6 502 Calculations
Vol. 19 No. 6 504 Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules
Vol. 19 No. 6 505 Cefepime Hydrochloride 100-mg/mL Injection
Vol. 19 No. 6 506 Cefotaxime 100-mg/mL Injection
Vol. 19 No. 6 507 Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Vol. 19 No. 6 508 Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Vol. 19 No. 6 509 Estradiol Valerate 40-mg/mL in Oil Injection
Vol. 19 No. 6 510 Levetiracetam 100-mg/mL Injection (Concentrate)
Vol. 19 No. 6 511 Memantine Hydrochloride Capsules
Vol. 19 No. 6 512 Mupirocin 2% Nasal Ointment
Vol. 19 No. 6 513 Propranolol Hydrochloride Capsules
Vol. 19 No. 6 514 Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Vol. 19 No. 6 521 Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment
Vol. 19 No. 6 525 PostScription: Pharmacy Fellowship Program: Building a Stronger Profession